NasdaqCM - Nasdaq Real Time Price USD

X4 Pharmaceuticals, Inc. (XFOR)

3.3700
+0.0800
+(2.43%)
At close: May 9 at 4:00:02 PM EDT
3.4400
+0.07
+(2.08%)
After hours: May 9 at 7:57:57 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
31,364
2,557
0
0
0
Cost of Revenue
5,513
797
0
0
--
Gross Profit
25,851
1,760
0
0
--
Operating Expense
139,406
143,161
107,522
88,078
75,349
Operating Income
-113,555
-141,401
-107,522
-88,078
-75,349
Net Non Operating Interest Income Expense
-3,367
-2,999
-1,195
-3,774
-3,632
Other Income Expense
131,845
107,260
7,628
-1,987
-9,698
Pretax Income
14,923
-37,140
-101,089
-93,839
-88,679
Tax Provision
325
310
78
28
17
Net Income Common Stockholders
14,598
-37,450
-101,167
-96,413
-102,639
Diluted NI Available to Com Stockholders
14,598
-37,450
-101,167
-96,413
-102,639
Basic EPS
2.11
-5.70
-17.10
-45.60
-119.70
Diluted EPS
2.11
-5.70
-17.10
-45.60
-119.70
Basic Average Shares
6,745.4850
6,702.0730
5,927.0820
2,117.5330
858.2990
Diluted Average Shares
6,752.7480
6,702.0730
5,927.0820
2,117.5330
858.2990
Total Operating Income as Reported
-8,555
-36,401
-107,522
-87,569
-85,107
Total Expenses
144,919
143,958
107,522
88,078
75,349
Net Income from Continuing & Discontinued Operation
14,598
-37,450
-101,167
-93,867
-88,696
Normalized Income
-114,050.8490
-121,923.1200
-106,755.4600
-95,612.9000
-81,305.4800
Interest Income
5,728
5,769
4,582
219
10
Interest Expense
9,095
8,768
5,777
3,993
3,642
Net Interest Income
-3,367
-2,999
-1,195
-3,774
-3,632
EBIT
24,018
-28,372
-95,312
-89,846
-85,037
EBITDA
25,228
-27,576
-94,893
-89,333
-84,538
Reconciled Cost of Revenue
5,513
797
0
0
--
Reconciled Depreciation
1,210
796
419
513
499
Net Income from Continuing Operation Net Minority Interest
14,598
-37,450
-101,167
-93,867
-88,696
Total Unusual Items Excluding Goodwill
131,513
106,928
7,074
2,210
-10,124
Total Unusual Items
131,513
106,928
7,074
2,210
-10,124
Normalized EBITDA
-106,285
-134,504
-101,967
-91,543
-74,414
Tax Rate for Calcs
0
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
2,864.1510
22,454.8800
1,485.5400
464.1000
-2,733.4800
12/31/2021 - 11/16/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNTB Connect Biopharma Holdings Limited
0.8098
+1.23%
 
MIST Milestone Pharmaceuticals Inc.
1.1100
-7.50%
 
DAWN Day One Biopharmaceuticals, Inc.
6.45
-4.59%
 
PDSB PDS Biotechnology Corporation
1.2000
-1.64%
 
GRCE Grace Therapeutics, Inc.
2.7200
-2.86%
 
VTGN Vistagen Therapeutics, Inc.
2.2400
-0.44%
 
VNDA Vanda Pharmaceuticals Inc.
3.9500
-6.40%
 
MNPR Monopar Therapeutics Inc.
39.42
-6.96%
 
FDMT 4D Molecular Therapeutics, Inc.
3.0800
-4.94%
 
ARDX Ardelyx, Inc.
3.6200
-0.55%